Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-292713
Filing Date
2023-12-11
Accepted
2023-12-11 17:21:57
Documents
1
Group Members
FAIRMOUNT HEALTHCARE CO-INVEST LPFAIRMOUNT HEALTHCARE FUND II LPFAIRMOUNT HEALTHCARE FUND LPPETER HARWINTOMAS KISELAK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d615568dsc13da.htm SC 13D/A 124768
  Complete submission text file 0001193125-23-292713.txt   126646
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89456 | Film No.: 231479027
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

EIN.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A